Monheit Law Monheit Law - Personal Injury Attorneys
Trasylol Lawsuit & News Blog

Blog Home
Category Index
Trasylol - Kidney Failure & Stroke - Dialysis Centers and Stroke Resources


Blog Home : Trasylol Lawsuit & News Blog

Bayer Has a Big Headache

Not tonight dear, Bayer has a headache, despite 2007 being a very good year for Bayer's profits and shareholders.

The bad news is that 2008 had some major setbacks. Among them is that Trasylol, a drug used in more than 33 percent of people undergoing heart surgeries are administered Trasylol. So far there are more than 200 lawsuits pending in federal courts.

According to Jim Ronca, a partner at the Philadelphia personal injury law firm Anapol Schwartz, "Now with the growing body of scientific evidence showing that the risks of Trasylol outweigh the benefits, the number of cases could increase substantially, potentially by tenfold."

A great deal of controversy follows Trasylol from the studies and findings questioning Trasylol's safety and effectiveness. Also if the FDA had removed Trasylol after the first study's findings in January 2006, instead of waiting until November 2007, some 22,000 lives could have been saved.

Other headaches for Bayer include scrapping a promising new drug that was being tested for lung cancer. The drug is approved to treat other kinds of cancer but Bayer was counting on this drug to bring in billions for lung cancer.

Also a heart medicine was pulled from the market because of intellectual property rights. It looks like 2008 is a year of wrongs. Stay tuned.

Source: Business Week

Heart Bypass Surgery Drug Causing Kidney/Renal Failure Suspended; Anapol Schwartz Attorney -- Representing Victims -- Says Situation Could Be Next Baycol

PHILADELPHIA--(BUSINESS WIRE)--According to Trasylol Lawyer, James Ronca, Esq., of law firm Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C., Bayer AG's announcement today that it would suspend sales of blood-clotting drug Trasylol, could lead to a situation in which Trasylol Lawsuits become Bayer's next Baycol. Trasylol is used in coronary artery bypass graft (CABG) procedures and found to cause kidney/renal failure.

Read More: Business Wire

Kidney Damage Increases with Coronary Artery Bypass Surgery

Researchers at Duke University Medical Center found that the incidence of acute kidney failure associated with coronary artery bypass surgery increased almost five-fold during the study period. The researchers estimate that approximately 20,000 cases of the... (Read Article)

Bayer Suspends Two Employees over Trasylol Data

Friday-October 13, Bayer AG suspended two senior employees over the company's failure to provide U.S. regulators with data on its heart-surgery drug Trasylol. Bayer also said it had hired an independent counsel to investigate its actions regarding the disclosure... (Read Article)

Bayer Purposely Does Not Disclose Trasylol Dangers

Failure by the German pharmaceutical giant Bayer to inform the Food and Drug Administration of the disquieting results of a large observational study cannot be easily dismissed with an apology. Circumstances suggest that Bayer sought to hide the results and... (Read Article)

Bayer Discloses Trasylol (aprotinin) Trials Not Disclose Facts

On September 29, 2006, as reported in Yahoo, German-based Bayer acknowledged that it mistakenly did not inform the U.S. Food and Drug Administration about a retrospective study commissioned by the company to analyze the effects of aprotinin, aminocaproic acid,... (Read Article)

October 2006 « 

Philadelphia Lawyers - Pennsylvania Lawsuits at Monheit Law

Law Offices of Michael Monheit 1368 Barrowdale Road  Rydal, PA  19046
Call Us Toll Free: 866-761-1385  P: 215-840-6573  E: